Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Medical ghost-writing influences doctors to prescribe more drugs

Daniel J. Carlat, MD
Meds
October 1, 2009
Share
Tweet
Share

Recently, a former staff medical writer at a MECC (Medical Education Communication Company) anonymously alerted me to a particularly sleazy advertising tactic used by a medical writing company. This person had worked as a pharma-supported medical writer for several years, but recently quit because, “I really couldn’t stomach the ethical problems associated with writing for the pharma industry.” Recently, looking for medical writing jobs, this writer came across a company called “Emron–” no, not Enron, although the ethical standards of the sound-alike companies appear to be similar.

Here is how Emron advertises its writing services to the pharmaceutical industry:

When you’re looking to compete on quality, set your sights on Emron for top-flight health care marketing communications and brand management. We drive sales, access and reimbursement in competitive markets: our clients achieve sustained competitive advantage by creating product demand and reducing price-sensitivity.

Now, if Emron were simply an advertising company, I would have no problem with this. Ad copy writers specialize in the craft of helping companies gain market share. As a newsletter publisher, I appreciate the magic of good marketing copy when I am periodically forced to send out those annoying promotional mailers that most people toss into recycling.

But Emron does much more than advertising. It produces accredited CME programs in order to help their clients “achieve sustained competitive advantage.” As the medical writer pointed out to me, the worst part of Emron’s statement is the phrase “reducing price sensitivity.” With healthcare costs being foremost in the nations’ consciousness right now, this attitude is unconscionable. Emron is saying to pharmaceutical companies “To heck with healthcare costs! The pharmaceutical industry should not do anything to compromise their profit margins. And we will offer you our professional staff of writers (for a hefty fee) to write your CME so that doctors will prescribe more of the most expensive drugs.”

One example of Emron’s work is the The Contraception Report, a Wyeth-funded newsletter whose underlying purpose is to get doctors interested in Wyeth’s latest birth control products. That newsletter has expanded into a website called Contraception Online, which is also entirely funded by Wyeth, and which also provides advertising dressed up as CME. This site is shamefully produced by Baylor College of Medicine; I don’t know what part Emron still plays in it, as the website does a good job of making this opaque.

Recently, Murray Kopelow provided testimony in which he assured the Senate Special Committee on Aging that ACCME is the firewall between education and promotion. Emron’s toll-free number is 800-367-6613. I suggest Dr. Kopelow give them a call to help them build a better firewall.

Daniel Carlat is a psychiatrist who blogs at The Carlat Psychiatry Blog.

Submit a guest post and be heard.

Prev

What was surgery like in the 1930s?

October 1, 2009 Kevin 0
…
Next

2009 H1N1 influenza - the pandemic continues

October 1, 2009 Kevin 0
…

Tagged as: Medications, Patients, Primary Care, Specialist

Post navigation

< Previous Post
What was surgery like in the 1930s?
Next Post >
2009 H1N1 influenza - the pandemic continues

ADVERTISEMENT

More by Daniel J. Carlat, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Elimination of industry support for CME

    Daniel J. Carlat, MD
  • a desk with keyboard and ipad with the kevinmd logo

    The decision point psychiatrists faced with psychotherapy

    Daniel J. Carlat, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Should the FDA have rejected Contrave?

    Daniel J. Carlat, MD

More in Meds

  • U.S. opioid policy history: How politics replaced science in pain care

    Richard A. Lawhern, PhD & Stephen E. Nadeau, MD
  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Deductive reasoning in medical malpractice: a quantitative approach

      Howard Smith, MD | Physician
    • Building a clinical simulation app without an MD: a developer’s guide

      Helena Kaso, MPA | Tech
    • Post-stroke cognitive impairment: the hidden challenge of recovery

      Rida Ghani | Conditions
    • The milkweed and the wind: a poem on aging as renewal

      Michele Luckenbaugh | Conditions
    • The cost of certainty in modern medicine

      Priya Dudhat | Education
    • Blaming younger doctors for setting boundaries ignores the broken system [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Deductive reasoning in medical malpractice: a quantitative approach

      Howard Smith, MD | Physician
    • Building a clinical simulation app without an MD: a developer’s guide

      Helena Kaso, MPA | Tech
    • Post-stroke cognitive impairment: the hidden challenge of recovery

      Rida Ghani | Conditions
    • The milkweed and the wind: a poem on aging as renewal

      Michele Luckenbaugh | Conditions
    • The cost of certainty in modern medicine

      Priya Dudhat | Education
    • Blaming younger doctors for setting boundaries ignores the broken system [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Medical ghost-writing influences doctors to prescribe more drugs
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...